Skip to main content

Eli Lilly signals beyond the news: 77+ signals from 6 sources

The latest Eli Lilly signal on this page is from Nov 17, 2026 (Patents): "Eli Lilly and Company's patent output is accelerating: 90 grants in the past year, 10 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Reddit (13).

Public (LLY)Pharmaceutical Manufacturing10,000+ employeeslilly.comLinkedIn

Get Eli Lilly's live signals in Claude or ChatGPT, or by API

AskWhat changed at Eli Lilly this week? Use Autobound signals for lilly.com.
Signals
77+
Sources
6
Last 90 days
73
Latest
Nov 17, 2026

Source: Autobound Signal API · 114 signals tracked for Eli Lilly · updated

Other signals · latest 10

Latest Eli Lilly signals by source

77+ signals for Eli Lilly across 6 sources.

  1. Patents · Patent pace

    Eli Lilly and Company's patent output is accelerating: 90 grants in the past year, 10 in the past 30 days.

    Over the past year Eli Lilly and Company received 90 US patent grants, concentrated in health tech / medical informatics and computer vision; the recent pace (30 in 90 days) is accelerating versus its trailing baseline.

    Grants, 12 months
    90
    Grants, 90 days
    30
    Grants, 30 days
    10
    Pace
    Accelerating

    Google Patents

  2. Patents · Patent grant

    Eli Lilly was granted a patent for KRAS G12C inhibitor compounds

    In November 2026 Eli Lilly patented drug candidates intended for treating cancer driven by KRAS G12C mutations.

    Patent title
    KRas G12C inhibitors
    Grant date
    Nov 17, 2026
    Inventors
    Serge Louis Boulet, Kevin Charles Fortner, Deqi Guo, David Michael Hyman

    Google Patents

  3. X (Twitter)

    Lilly announces newest U.S. manufacturing site in Lehigh Valley, creating 850 jobs for injectable medicines.

    Lehigh Valley, PA: Our newest U.S. manufacturing site. This facility will use advanced technologies to help scale production of safe, high-quality injectable medicines, add capacity for advancements in obesity treatment & create 850 high-wage jobs. https://t.co/fG78ne9ows https://t.co/2Tfzxf7FMn

    Account
    @EliLillyandCo
    Views
    1,665
    Likes
    23
    Reposts
    1

    X (@EliLillyandCo)

  4. LinkedIn

    Lilly presents 52-week exploratory analyses of two medicines for psoriatic arthritis and obesity.

    For people living with psoriatic arthritis (PsA) and obesity, meaningful progress isn’t defined by a single measure. Beyond disease activity, it can also be reflected in fatigue, physical function and other outcomes that matter to daily life. New 52-week exploratory analyses from the Phase 3b TOGETHER-PsA study...

    Likes
    117
    Comments
    5
    Tags
    Pharmaceuticals, Medical Research
    Initiatives
    Phase 3b TOGETHER-PsA study results

    LinkedIn

  5. X (Twitter)

    Eli Lilly shares one-year TOGETHER-PsA exploratory analysis results at ACR2026 conference.

    Meaningful progress isn’t defined by a single measure. New one-year TOGETHER-PsA exploratory analyses showed improved and durable efficacy, patient-reported and metabolic outcomes for people living with psoriatic arthritis and obesity. #ACR2026 https://t.co/yiCwJ4Esyk https://t.co/3V3hMATKuh

    Account
    @EliLillyandCo
    Views
    1,969
    Likes
    14
    Reposts
    1

    X (@EliLillyandCo)

  6. Glassdoor · Rapid growth pains

    Scaling company reports resource shortages and workspace constraints

    Employees mention that aggressive growth has led to a lack of dedicated workstations, insufficient parking, and a general do more with less culture that strains resources.

    Overall rating
    4.0 of 5
    CEO approval
    89%
    Reviews read
    9
    Review window
    Nov 1, 2026 to Nov 9, 2026

    Glassdoor

  7. Glassdoor · Consistent leadership complaints

    Employees report pervasive toxic leadership and lack of honest communication

    Multiple employees describe a senior leadership team characterized by favoritism and poor communication, where honesty is not valued and managers prioritize loyalty over genuine feedback.

    Overall rating
    4.0 of 5
    CEO approval
    89%
    Reviews read
    9
    Review window
    Nov 1, 2026 to Nov 9, 2026

    Glassdoor

  8. LinkedIn

    Eli Lilly presents Phase 3 ATTAIN-OSA trial results for its GLP-1 pill in sleep apnea.

    Obstructive sleep apnea (OSA) is a common and often undertreated contributor to cardiovascular risk. In the Phase 3 ATTAIN-OSA trial, our GLP-1 pill significantly reduced the apnea-hypopnea index (AHI) and improved key cardiovascular risk factors in adults with moderate-to-severe OSA and obesity. These results...

    Likes
    328
    Comments
    8
    Tags
    Medical Research, Pharmaceuticals, Clinical Operations
    Initiatives
    GLP-1 pill Phase 3 trial results

    LinkedIn

  9. Podcasts · Sponsorship

    Eli Lilly sponsors Closing Bell

    Finding lung cancer early can significantly increase your chance of survival. If you're 50 or older with a history of smoking, ask your doctor about lung cancer screening. Learn more at go.lily.com slash SiriusXM.

    Podcast
    Closing Bell
    Episode
    Closing Bell Overtime: Tech Stocks Plunge Markets Search for A Bottom 11/5/26

    Closing Bell

  10. Reddit · Layoffs

    Eli Lilly is conducting stealth layoffs and re-organizations, confirmed first-hand by multiple recently laid-off employees.

    Post: "I left a good job..."

    Subreddit
    r/biotech
    Upvotes
    340
    Comments
    77
    Sentiment
    Negative

    r/biotech

Showing 10 of 77+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Eli Lilly with the Signal API

One POST /v1/companies/enrich call with lilly.com returns Eli Lilly signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "lilly.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about Eli Lilly other signals

What signals does Autobound track for Eli Lilly besides news and filings?
This page lists 77+ signals for Eli Lilly from 6 sources: Glassdoor (15+), LinkedIn (15+), Reddit (13), X (Twitter) (12), Podcasts (11) and Patents (11). Every row is dated, and most link to the post, review or record.
What are people saying about Eli Lilly online?
The newest posts on this page: Nov 13, 2026, X (Twitter) (X (@EliLillyandCo)): Lilly announces newest U.S. manufacturing site in Lehigh Valley, creating 850 jobs for injectable medicines. Nov 11, 2026, X (Twitter) (X (@EliLillyandCo)): Eli Lilly shares one-year TOGETHER-PsA exploratory analysis results at ACR2026 conference. Nov 9, 2026, X (Twitter) (X (@EliLillyandCo)): Eli Lilly presents oral GLP-1 pill data for obstructive sleep apnea at Scientific Sessions.
What do employees say about working at Eli Lilly?
The newest Glassdoor theme on this page, dated Nov 9, 2026: Scaling company reports resource shortages and workspace constraints. The overall rating in that row is 4.0 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Eli Lilly been granted patents recently?
Yes. The newest grant on this page: Nov 17, 2026, Patents (Google Patents): Eli Lilly was granted a patent for KRAS G12C inhibitor compounds.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →